AmeriPharma’s premier pharmacy services are available in multiple states throughout the US.

Related Posts

Get Financial Relief Now

Apply for Jakafi Copay Assistance

Free service matches you with top copay assistance programs

Specialists assist you throughout the application process

Get automated updates on your funding status

Over $55 million secured for our patients to date

How Much Can You Save?

Speak With a Copay Assistance Specialist

We accept Medicare, Medi-Cal and most private insurances.

Medi-Cal logo
LegitScript approved

Get Started in Minutes

How Jakafi Copay Assistance Works

plus icon with transparent background

1 – Check Your Coverage/Benefits Verification

Our team of expert billers finds the best avenues of coverage that minimize out-of-pocket costs.

Rx icon

2 – Transfer Prescription to AmeriPharma

We process your prescription by working with your previous pharmacy or prescriber, making the transition quick and easy.

document icon with transparent background

3 – Prior Authorization

Our team of specialists obtains approval from your insurance companies within 24 to 72 hours.

document and personnel icon with transparent background

4 – Copay Assistance & Financial Aid

We secure financial aid and decrease copays, out-of-pocket expenses, and high deductibles. To date, AmeriPharma Specialty Care has secured $55 million in financial assistance for our patients.

3 hands and plus icon with transparent background

5 – Nursing Care Coordination

AmeriPharma puts your schedule and home environment first when scheduling and coordinating one of our specialized nurses for your in-home infusions.

box icon with transparent background

6 – Delivery Coordination

Medications are always delivered in strict compliance with the specific requirements for immune globulin shipping. Next-day and overnight cold-chain deliveries are coordinated around your schedule.

Speak With a Specialist

We accept Medicare, Medi-Cal and most private insurances. Call us to find out more about your coverage.

What Is Jakafi?

Jakafi (ruxolitinib) is a protein kinase inhibitor that inhibits certain enzymes called Janus kinases (JAK), which are involved in the production and growth of red blood cells.

In myelofibrosis (bone marrow cancer) or polycythemia vera (a rare blood disorder), the Janus kinases are overactive, which leads to uncontrolled production of blood cells that can migrate to other organs such as the spleen and cause enlargement. Jakafi inhibits specific signaling pathways and thus stops this overproduction of blood cells.

Schedule a Consultation

We accept Medicare, Medi-Cal and most private insurances. Call us to find out more about your coverage.

What Is Jakafi Used For?

  • Myelofibrosis: Jakafi is indicated for the treatment of intermediate or high-risk myelofibrosis (MF). This includes primary MF, post-polycythemia vera MF and post-essential thrombocythemia MF in adults. 
  • Polycythemia vera: Jakafi is indicated for the treatment of polycythemia vera (PV) for adults who have experienced an inadequate response to or intolerance of hydroxyurea.
  • Acute graft-versus-host disease: Jakafi is indicated for the treatment of steroid-refractory acute graft-versus-host disease (aGVHD) in adults and pediatric patients who are over 12 years of age. 
  • Chronic graft-versus-host disease: Jakafi is indicated for the treatment of chronic graft-versus-host disease (cGVHD) in adults and pediatric patients (over 12) after failure of one or two lines of systemic therapy.

Duration of Therapy

Your doctor may allow up to 6 months to see if Jakafi works for you. If there is no improvement after 6 months of treatment, your doctor may have you stop taking the medication.

It is important you take Jakafi exactly as prescribed. Do not stop taking it without speaking to your doctor first. The only exception is if you start bleeding. If this happens, stop taking Jakafi and call your doctor immediately.

Copay and Financial Assistance

AmeriPharma Specialty Care alleviates financial burdens for patients and their families

Advanced software icon
Advanced software locates funding sources to match you with top-dollar foundation programs
Copay assistance icon
One of our copay assistance specialists will assist with the application process
Funding status icon
Automatic updates will be sent to you and your physician on the status of the funding

Speak With a Specialist

We accept Medicare, Medi-Cal and most private insurances. Call us to find out more about your coverage.

Jakafi Side Effects

The most common side effects include:
  • Thrombocytopenia (low platelets)
  • Anemia (low red blood cell counts) 
  • Neutropenia (low white blood cell counts)
  • Risk of infection (i.e., tuberculosis, progressive multifocal leukoencephalopathy, herpes zoster, and hepatitis B) 
  • Bruising
  • Dizziness
  • Headache
  • Diarrhea

Schedule a Consultation

We accept Medicare, Medi-Cal and most private insurances. Call us to find out more about your coverage.

Dosage

Myelofibrosis

The recommended starting dose is based on platelet count:  

  • For platelets between 50,000/mm³ and 100,000/mm³ : 5 mg twice daily
  • For platelets between 100,000/mm³ and 200,000/mm³ : 15 mg twice daily
  • For platelets > 200,000/mm³ : 20 mg twice daily

Blood work is done before initiating therapy, every 2 to 4 weeks until doses are stabilized, and then as clinically indicated. 

Doses will be titrated and adjusted by your doctor based on safety, efficacy, and ongoing platelet count.

Polycythemia Vera

For polycythemia vera, the recommended dose is 10 mg twice daily.

Blood work is done before initiating therapy, every 2 to 4 weeks until doses are stabilized, and then as clinically indicated. 

Doses will be titrated and adjusted by your doctor based on safety, efficacy, and ongoing hemoglobin and platelet count.

Acute Graft-Versus-Host Disease

For acute graft-versus-host disease, the recommended dose is 5 mg given orally twice daily.

Blood work is done before initiating therapy, every 2 to 4 weeks until doses are stabilized, and then as clinically indicated. 

Doses will be titrated and adjusted by your doctor based on safety, efficacy, and ongoing absolute neutrophil count (ANC) and bilirubin level.

Chronic Graft-Versus-Host Disease

For chronic graft-versus-host disease, the recommended dose is 10 mg given orally twice daily.

Blood work is done before initiating therapy, every 2 to 4 weeks until doses are stabilized, and then as clinically indicated.  

Doses will be titrated and adjusted by your physician based on safety, efficacy, and ongoing ANC and bilirubin level.

How Much Can You Save?

Speak With a Copay Assistance Specialist

© 2022 AmeriPharma Specialty Care. All Rights Reserved.  132 S. Anita Dr. Suite 310, Orange, CA 92868. Privacy Policy | Terms of use
Schedule a Consultation